General social media, as exemplified by sample data from Facebook and Twitter, are not recommended for broad statistical signal detection.

Social media channels may provide a useful adjunct to pharmacovigilance activities in specific niche areas such as exposure during pregnancy and abuse/misuse of medicines.

Future enhancement of adverse event recognition algorithms may broaden the scope and utility of social media over time.